NICE recommends cenobamate for treatment of adult epilepsy patients in UK
Summary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
Summary : NICE has issued a positive recommendation for Arvelle Therapeutics’ cenobamate (Ontozry), for the treatment of focal-onset seizures in adults with…
Summary : New Syniverse CPaaS Platform to Accelerate Enterprises’ Digital Transformation and Improve Customer Experience The Syniverse Hyperscale Communications Platform allows enterprises…
Summary : For years, researchers interested in treating amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) have struggled to understand why variants…
Summary : Topline data of the main cohort of AAVance clinical trial expected in Q3 2022 Stabilization or decreased size of white…
Summary : VivoPower International PLC (NASDAQ: VVPR) (“VivoPower,” the “Company”) is pleased to announce that its wholly-owned subsidiary in Australia, Kenshaw Electrical…
Synopsis : Rare viral haemorrhagic disease similar to Ebola surface in the East of England. Two people in the UK have been…
Summary : Dr Reddy’s Laboratories on Thursday stated it has inked a pact to acquire Germany-based Nimbus Health GmbH. The drug main…
Summary : Consumer protection regulator CCPA has passed an order against GlaxoSmithKline (GSK) Consumer Healthcare Ltd directing it to discontinue advertisements of…
Synopsis : An investment consortium led by Signet Healthcare Partners, Bionpharma, Inc and GMS Capital Partners LLC today announced it has formed…
Summary : The life science group Sartorius announced today that, through its subgroup Sartorius Stedim Biotech, it closed the acquisition of the…